ATE340571T1 - Pharmazeutische zubereitungen enthaltend beta- turn peptidomimetische zyklische substanzen - Google Patents

Pharmazeutische zubereitungen enthaltend beta- turn peptidomimetische zyklische substanzen

Info

Publication number
ATE340571T1
ATE340571T1 AT01942551T AT01942551T ATE340571T1 AT E340571 T1 ATE340571 T1 AT E340571T1 AT 01942551 T AT01942551 T AT 01942551T AT 01942551 T AT01942551 T AT 01942551T AT E340571 T1 ATE340571 T1 AT E340571T1
Authority
AT
Austria
Prior art keywords
trka
turn
beta
extracellular domain
peptidomimmetic
Prior art date
Application number
AT01942551T
Other languages
English (en)
Inventor
Horacio Uri Saragovi
Kevin Burgess
Original Assignee
Univ Mcgill
Texas A & M Univ Sys
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mcgill, Texas A & M Univ Sys filed Critical Univ Mcgill
Application granted granted Critical
Publication of ATE340571T1 publication Critical patent/ATE340571T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01942551T 2000-01-18 2001-01-18 Pharmazeutische zubereitungen enthaltend beta- turn peptidomimetische zyklische substanzen ATE340571T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17648200P 2000-01-18 2000-01-18

Publications (1)

Publication Number Publication Date
ATE340571T1 true ATE340571T1 (de) 2006-10-15

Family

ID=22644525

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01942551T ATE340571T1 (de) 2000-01-18 2001-01-18 Pharmazeutische zubereitungen enthaltend beta- turn peptidomimetische zyklische substanzen

Country Status (9)

Country Link
US (1) US6881719B2 (de)
EP (1) EP1265605B1 (de)
AT (1) ATE340571T1 (de)
AU (1) AU2001228212A1 (de)
CA (1) CA2397670C (de)
DE (1) DE60123399T2 (de)
DK (1) DK1265605T3 (de)
ES (1) ES2273849T3 (de)
WO (1) WO2001052843A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7923216B2 (en) 1997-08-14 2011-04-12 Institut Pasteur In vivo modulation of neuronal transport
US7923015B2 (en) 1997-08-14 2011-04-12 Institut Pasteur Methods for direct visualization of active synapses
US7566765B2 (en) * 2000-03-06 2009-07-28 Rigel Pharmaceuticals, Inc. Heterocyclic compounds containing a nine-membered carbon-nitrogen ring
EP1575477B1 (de) * 2001-05-25 2012-04-25 Cornell Research Foundation, Inc. HOCHAFFINER LIGAND FÜR p75 NEUROTROPHIN-REZEPTOR
AUPR604401A0 (en) 2001-06-29 2001-07-26 University Of Wollongong, The Peptoid compounds
US7252822B2 (en) 2002-10-08 2007-08-07 Rinat Neuroscience Corp. Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist
US7255860B2 (en) 2002-10-08 2007-08-14 Rinat Neuroscience Corp. Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody
CN102746399B (zh) 2002-12-24 2016-03-02 里纳特神经系统学公司 抗ngf抗体及其使用方法
US9498530B2 (en) 2002-12-24 2016-11-22 Rinat Neuroscience Corp. Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
US7569364B2 (en) 2002-12-24 2009-08-04 Pfizer Inc. Anti-NGF antibodies and methods using same
EP2902491A1 (de) 2003-03-19 2015-08-05 Biogen MA Inc. NOGO Rezeptor bindendes Protein
WO2004111077A1 (en) 2003-06-18 2004-12-23 Tranzyme Pharma Inc. Macrocyclic antagonists of the motilin receptor
ITRM20030601A1 (it) * 2003-12-24 2005-06-25 Lay Line Genomics Spa Metodo per l'umanizzazione di anticorpi e anticorpi umanizzati con esso ottenuti.
PL1732949T3 (pl) 2004-04-07 2010-06-30 Rinat Neuroscience Corp Sposoby leczenia nowotworowego bólu kości przez podawanie antagonisty czynnika wzrostu nerwów
EP1776136B1 (de) 2004-06-24 2012-10-03 Biogen Idec MA Inc. Behandlung von entmyelinisierenden erkrankungen
CA2571130C (en) * 2004-07-14 2014-08-19 Janssen Pharmaceutica N.V. P75ntr screening assay for indentifying modulators of apoptosis
WO2006052391A2 (en) * 2004-10-14 2006-05-18 Rigel Pharmaceuticals, Inc. Heterocyclic inhibitors of ires-mediated translation and methods of use thereof
JP2008536844A (ja) * 2005-04-15 2008-09-11 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル ニューロトロフィン類似体を用いた細胞生存促進法
US20110230479A1 (en) * 2005-04-15 2011-09-22 Longo Frank M Neurotrophin mimetics and uses thereof
ITRM20050290A1 (it) * 2005-06-07 2006-12-08 Lay Line Genomics Spa Uso di molecole in grado di inibire il legame tra ngf e il suo recettore trka come analgesici ad effetto prolungato.
US8686045B2 (en) * 2005-06-08 2014-04-01 The University Of North Carolina At Chapel Hill Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics
AU2006269458B2 (en) 2005-07-08 2012-11-08 Biogen Ma Inc. Sp35 antibodies and uses thereof
EP2068866A4 (de) 2006-07-24 2010-04-07 Biogen Idec Inc Verfahren zur förderung von myelinisierung, neuronalem überleben und oligodendrozytendifferenzierung mittels verabreichung von sp35- bzw. trka-antagonisten
WO2008070132A2 (en) * 2006-12-05 2008-06-12 The Royal Institution For The Advancement Of Learning/ Mcgill University Methods of use of trk receptor modulators
AU2011253937B2 (en) * 2006-12-05 2012-09-27 The Royal Institution For The Advancement Of Learning/ Mcgill University Methods of use of TRK receptor modulators
CA2701189C (en) * 2007-10-11 2017-05-16 Biogen Idec Ma Inc. Methods for treating pressure induced optic neuropathy, preventing neuronal degeneration and promoting neuronal cell survival via administration of lingo-1 antagonists and trkb agonists
JP5754046B2 (ja) * 2007-11-08 2015-07-22 バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． 脱髄を伴う状態の治療におけるｌｉｎｇｏ−４アンタゴニストの使用
KR101565185B1 (ko) * 2008-04-04 2015-11-02 미메토젠 파르마슈티칼스 인크. 건안증을 치료하기 위한 베타-턴 펩티도미메틱 환상 화합물
DK2982695T3 (da) 2008-07-09 2019-05-13 Biogen Ma Inc Sammensætninger, der omfatter antistoffer mod lingo eller fragmenter deraf
JP5663498B2 (ja) 2009-02-27 2015-02-04 ミメトゲン ファーマシュウティカルズ インコーポレイテッドＭｉｍｅｔｏｇｅｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 網膜色素変性症を処置するためのペプチド模倣環状化合物
CA2780940C (en) 2009-11-12 2021-08-31 Pharmatrophix, Inc. Crystalline forms of neurotrophin mimetic compounds and their salts
US10273219B2 (en) 2009-11-12 2019-04-30 Pharmatrophix, Inc. Crystalline forms of neurotrophin mimetic compounds and their salts
NZ702178A (en) 2012-05-14 2017-01-27 Biogen Ma Inc Lingo-2 antagonists for treatment of conditions involving motor neurons
JP6248103B2 (ja) * 2012-06-22 2017-12-13 ミメトゲン ファーマシュウティカルズ インコーポレイテッドＭｉｍｅｔｏｇｅｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． β−ターン環式ペプチド模倣化合物の合成
WO2014144342A1 (en) 2013-03-15 2014-09-18 Pharmatrophix, Inc. Non-peptide bdnf neurotrophin mimetics
CA2901839A1 (en) 2013-03-15 2014-09-18 Pharmatrophix, Inc. Non-peptide bdnf neurotrophin mimetics
CN105744944B (zh) 2013-09-09 2020-07-07 卡尼姆盖德治疗学公司 免疫系统调节器
WO2016112270A1 (en) 2015-01-08 2016-07-14 Biogen Ma Inc. Lingo-1 antagonists and uses for treatment of demyelinating disorders
WO2016144650A1 (en) 2015-03-06 2016-09-15 Canimguide Therapeutics Ab Immune system modulators and compositions
EP4549450A3 (de) 2015-07-09 2025-07-02 Mimetogen Pharmaceuticals, Inc. Lösungsphasensynthese und kristallisation von beta-turn-peptidomimetischen cyclischen salzen
EP4180446A4 (de) * 2020-07-10 2024-11-06 The University of Tokyo Cyclisches peptid, peptidkomplex und arzneimittelzusammensetzung mit dem cyclischen peptid und/oder dem peptidkomplex
WO2022256394A2 (en) * 2021-06-02 2022-12-08 The Texas A&M University System Selective small molecule agonists and partial agonists of trk receptors
EP4565253A2 (de) * 2022-08-05 2025-06-11 The Texas A&M University System Zusammensetzungen und verfahren für farbstoffgebundene zyklisierte peptide zur medizinischen verwendung
FR3148027A1 (fr) * 2023-04-24 2024-10-25 Peptinov Composition vaccinale anti-ngf

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034224A (en) * 1989-05-30 1991-07-23 American Cyanamid Company Method and composition for treating protozoal infections
DK0563256T3 (da) * 1990-12-21 1995-08-28 Microcarb Inc Anvendelse af værtscelle-phospholipider til inhibering af bakteriekolonisering
GB9402331D0 (en) * 1994-02-07 1994-03-30 Univ Mcgill Nerve growth factor structural analogs and their uses

Also Published As

Publication number Publication date
US20030211982A1 (en) 2003-11-13
EP1265605A1 (de) 2002-12-18
DE60123399T2 (de) 2007-08-23
DK1265605T3 (da) 2007-02-12
AU2001228212A1 (en) 2001-07-31
US6881719B2 (en) 2005-04-19
ES2273849T3 (es) 2007-05-16
DE60123399D1 (de) 2006-11-09
EP1265605B1 (de) 2006-09-27
CA2397670C (en) 2010-06-08
WO2001052843A1 (en) 2001-07-26
CA2397670A1 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
DE60123399D1 (de) Pharmazeutische zubereitungen enthaltend beta-turn peptidomimetische zyklische substanzen
Contreras et al. Antagonism of morphine-induced analgesia, tolerance and dependence by alpha-melanocyte-stimulating hormone.
Hopf et al. Dimerization of the muscle-specific kinase induces tyrosine phosphorylation of acetylcholine receptors and their aggregation on the surface of myotubes
BRPI0411155A (pt) composto que se liga a e ativa o receptor de eritropoietina, composição farmacêutica e seu uso
ATE381560T1 (de) Neue benzazepine und ähnliche heterocyclische derivate,die als orexin rezeptor antagonisten geeignet sind
BG101806A (bg) Индолови производни като антагонисти на 5-нт рецептори
ATE449076T1 (de) Imidazolderivate als histamin-h3-modulatoren
ATE377597T1 (de) Anilinochinazoline als protein-tyrosin- kinasehemmer
IT1306704B1 (it) Anticorpi monoclonali e suoi derivati sintetici o biotecnologici ingrado di agire come molecole antagoniste per il ngf.
Kamato et al. The expansion of GPCR transactivation-dependent signalling to include serine/threonine kinase receptors represents a new cell signalling frontier
TR200002015T2 (tr) Protein tirosin kinaz inhibitörleri olarak bisiklik heteroaromatik bileşikler.
Berg et al. Allosteric interactions between δ and κ opioid receptors in peripheral sensory neurons
BR9911621A (pt) Bifenil sulfonamidas como antagonista duplos de receptor de angiotensina endotelina
BR0015963A (pt) Compostos de uréia antagonistas receptor muscarìnico, composições farmacêuticas compreendendo tais compostos e método de preparação destes compostos
DE69636437D1 (de) Ligand polypeptide für hypophyse g-protein gekoppeltes rezeptor-protein, deren herstellung und anwendung
ATE293448T1 (de) Benzo(d)azepin-derivative als 5-ht6-rezeptor- antagonisten
ATE211737T1 (de) Tricyclisch substituierte 2,4-dithi(oxo)- pyrimidin-5-yl-verbindungen als p2- purinoceptor- antagonisten
Brahimi et al. Combinatorial assembly of small molecules into bivalent antagonists of TrkC or TrkA receptors
WO2005116052A3 (en) ANTAGONISM OF TGF-β SUPERFAMILY RECEPTOR SIGNALING
ATE266722T1 (de) Zyklische peptidomimetische urokinaserezeptorantagonisten
PT1042320E (pt) Novos compostos que sao antagonistas de receptores duplos de ourinoceptores p2 e de proteina g 7-transmembranar
ATE227276T1 (de) Neue pyrimidinderivate
ATE273389T1 (de) Rezeptor des y-y5 neuropeptids
DE60015187D1 (de) Urotensin-ii rezeptorantagonisten
Jales et al. Selective κ-opioid antagonists related to naltrindole. effect of side-chain spacer in the 5′-amidinoalkyl series

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties